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Abstract
Background
Autism spectrum disorders (ASDs) are characterised by impairments in communication and reciprocal social 
interaction. These impairments can impact on relationships with family members, augment stress and 
frustration, and contribute to behaviours that can be described as challenging. Family members of individuals 
with ASD can experience high rates of carer stress and burden, and poor parental efficacy. While there is 
evidence to suggest that individuals with ASD and family members derive benefit from psychological 
interventions designed to reduce stress and mental health morbidity, and enhance coping, most studies to 
date have targeted the needs of either individuals with ASD, or family members. We wanted to examine 
whether family (systemic) therapy, aimed at enhancing communication, relationships or coping, is effective for 
individuals with ASD and their wider family network.
Objectives
To evaluate the clinical effectiveness and acceptability of family therapy as a treatment to enhance 
communication or coping for individuals with ASD and their family members. If possible, we will also seek to 
establish the economic costs associated with family therapy for this clinical population.
Search methods
On 16 January 2017 we searched CENTRAL, MEDLINE, Embase, nine other databases and two trials 
registers. We also handsearched reference lists of existing systematic reviews and contacted study authors in 
the field.
Selection criteria
Randomised controlled trials (RCTs) and quasi-RCTs investigating the effectiveness of family therapy for 
young people or adults with ASD or family members, or both, delivered via any modality and for an unspecified 
duration, compared with either standard care, a wait-list control, or an active intervention such as an 
alternative type of psychological therapy.
Data collection and analysis
Two authors independently screened each title and abstract and all full-text reports retrieved. To enhance 
rigour, 25% of these were independently screened by a third author.
Main results
The search yielded 4809 records. Of these, we retrieved 37 full-text reports for further scrutiny, which we 
subsequently excluded as they did not meet the review inclusion criteria, and identified one study awaiting 
classification.
Authors' conclusions
Few studies have examined the effectiveness of family therapy for ASD, and none of these are RCTs. Further 
research studies employing methodologically robust trial designs are needed to establish whether family 
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therapy interventions are clinically beneficial for enhancing communication, strengthening relationships, 
augmenting coping and reducing mental health morbidity for individuals with ASD and family members.
Plain language summary
Family therapy for autism spectrum disorders 
Review question
What is the evidence that family therapy can help to improve communication, strengthen relationships, and 
enhance coping, mental health and well-being for people who have autism spectrum disorders (ASDs) or their 
family members, or both?
Background
People with ASD often experience difficulty with knowing how to communicate with others, and with 
developing and maintaining friendships and relationships. They can also find it difficult to manage changes to 
their routine. People with ASD tend to rely on family members, including parents and siblings, well into 
adulthood. Family members of people with ASD sometimes experience stress, anxiety and depression.
Several research studies have investigated the benefits of talking therapies for individuals with ASD or for 
family members. While study findings suggest that these therapies can improve communication and coping, 
and mental health and well-being, outcomes are usually reported for the person with ASD or family members, 
but not both.
Family therapy is designed to help people within the family make sense of difficult situations, and help them 
work together to develop new ways of thinking about and managing these difficulties. It is important to find out 
if family therapy can be helpful for people with ASD and their relatives given that the core symptoms of ASD, 
and additional difficulties people can experience, often impact on the family unit.
We searched for all the available evidence, published or unpublished, up until 16 January 2017, which 
examined family therapy for ASD.
Study characteristics
While there have been a few studies investigating the benefits of family therapy interventions for ASD, none 
have compared family therapy with either no treatment, a group of people waiting to start treatment, or another 
type of psychological therapy. One study on youths with ASD and severe behavioural problems is under way, 
but we have no further information at this time.
Quality of the evidence
There is limited high-quality evidence available about whether family therapy is helpful for people with ASD or 
their family members. More research studies are needed to evaluate the effectiveness of family-focused 
interventions to enhance communication, reduce stress and improve coping.
Background
Description of the condition
Autism spectrum disorders (ASDs) are a cluster of childhood-onset, neurodevelopmental conditions 
characterised by qualitative impairments in communication, reciprocal social interaction, and restricted and 
repetitive interests and behaviours (WHO 1992). There is substantial heterogeneity in the ASD symptom 
profile and clinical presentation; hence, diagnosis is often not made until late adolescence or adulthood (NICE 
2012). Once thought to be fairly rare, current prevalence estimates indicate that ASD is relatively common, 
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affecting at least 1% of the population (Brugha 2011).
The degree of impairment resulting from core ASD characteristics varies widely. Educational attainments are 
often poorer for younger people with ASD in comparison to typically developing peers (Levy 2011). Similarly, 
the adult ASD population experiences significant difficulty with gaining and sustaining meaningful employment (
Howlin 2013; Mavranezouli 2014). A lack of peer and intimate relationships are frequently the norm (White 
2009a), leading to diminished social opportunities beyond those that stem from the family network, social 
isolation and loneliness. Daily living and self-sufficiency skills can also be impeded, and individuals with ASD 
often depend on ongoing support from family members well into adulthood (Gray 2014; Magiati 2014).
ASDs are commonly associated with learning disability and high rates of psychiatric comorbidity (Hofvander 
2009; Joshi 2013; Simonoff 2008), including anxiety disorders (Van Steensel 2011; White 
2009b), depression (Ghaziuddin 2002), attention deficit hyperactivity disorder traits (Taylor 2013), and more 
general "emotional and behavioural problems" (Maskey 2013). Comorbidities further compound difficulties 
across multiple domains of functioning and exacerbate reliance on family members as well as carer stress and 
burden (Cadman 2012).
The experiences and needs of family members of individuals with ASD have garnered increasing attention in 
recent years. Findings from epidemiological and genetic studies indicate that ASD is a highly heritable 
condition (Hallmayer 2011; Lichtenstein 2010; Lundström 2010). Also, studies have found that parents of 
people with ASD can present with higher levels of stress, distress, fatigue, anxiety, and depression symptoms 
than those reported for parents of typically developing or other clinical populations (Cadman 2012; Firth 2013; 
Giallo 2013; Hoefman 2014). Additionally, research findings suggest that carers can experience concerns 
about their parental efficacy and coping (Karst 2012), and that marital satisfaction can be affected 
(Hartley 2011). There has been some, albeit limited, research about siblings of individuals with ASD. Tentative 
study findings suggest that some siblings may experience slightly elevated levels of "behavioural problems" 
compared to non-clinical populations (Hastings 2014), or features of anxiety (Shivers 2013). Sibling 
adjustment and relationships may be affected by the severity of ASD and associated symptoms (Petalas 
2012; Rivers 2003). Siblings may also be expected to take on more household duties (e.g. chores), or more 
responsibility (e.g. informal caregiving) compared to the individual with ASD, although this is not a consistent 
finding across studies (Meirsschaut 2011).
Description of the intervention
Family therapy can be defined as a formal, psychotherapeutic intervention, which seeks to understand and 
enhance relationships, communication, and functioning between members of a family (Dallos 2010). While 
there are several types of family therapy, they are predominantly underpinned by systemic theories and share 
central tenets (Hayes 1991). First, it is proposed that various problems, such as mental health functioning or 
the development and maintenance of interpersonal relationships, are contextually bound (that is, they are likely 
to be predisposed and perpetuated by the context and system(s) within which they occur, rather than solely 
being attributed to the individual themselves) (Dallos 2010). Second, it is suggested that societal and cultural 
norms, values and expectations influence and shape familial beliefs and behaviours both collectively (that is, 
the intergenerational family unit) and individually, and that problems are best understood and addressed in 
terms of these influences. Third, it is hypothesised that the family unit and the relationships between family 
members are dynamic (that is, that the reactions and responses of one person affect those of others in the 
system, in a bi-directional fashion, linearly and longitudinally). Fourth, families are said to develop ways of 
coping with periods of change and transition (e.g. births, marriages and bereavements), and illness or 
adversity, in order to maintain stability as a unit (Goldenberg 2012). Often these patterns of coping are 
adaptive and shared between all family members; yet, on occasion, individuals (within the family) may adopt 
distinct coping styles leading to communication and relationship difficulties. Finally, it is considered that there 
are commonalities in the ways that family members use language and narratives to converse and make sense 
of their own and others  experiences but also subtle differences, which, in turn, may lead to or exacerbate 
ambiguity, misinterpretation or disagreements.
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Family therapists use a range of interventions (Dallos 2010), including psychoeducation; development of 
genograms to map out cultural, resilience or other familial patterns (Butler 2008); narrative techniques (e.g. to 
explore language, meanings and attributions) (Carr 1998); and the use of particular questioning styles (e.g. 
circular and reflexive questions to enhance the breadth and depth of discussion) (Hayes 1991). In clinical 
practice, individuals presenting for family therapy may be part of the same family or part of the wider friendship 
group. Individuals are encouraged to decide for themselves who can and will engage in treatment, and the 
configuration of those attending may vary from session to session. The duration of therapy can be several 
weeks to several months. Choices about the number of sessions to offer are largely dependent on the service 
model and constraints, familial presenting needs and the therapist s theoretical stance.
How the intervention might work
Family therapy for ASD can be hypothesised to work in several ways (Goepfert 2015; Helps 2016; Ramisch 
2013; Solomon 2012). Individuals with ASD and family members can be supported to understand and make 
sense of the diagnosis (e.g. through the use of psychoeducation). Discussion can be facilitated about 
preferences for using different terminology to describe the core symptoms (e.g. autism spectrum disorder  or 
autism spectrum condition ) and the narratives and meanings that arise from this for individuals and the family 
unit collectively. The impact of core characteristics (e.g. engagement in routines or impairments in 
socioemotional reciprocity such as a lack of empathy) can be explored with a view to reducing feelings of 
frustration or annoyance. Interventions can encourage discussion about broad factors and familial patterns or 
responses that may contribute to difficulties with communication and relationships or challenging behaviour, 
and support the identification of strategies to promote cohesion within the system. Family therapy can also 
encourage open dialogue between carers (e.g. about potential guilt or feelings of stress or worry), and, in turn, 
strategies can be developed to enhance marital relationships, resilience and coping, and positive parental 
mental health. Family therapy also provides a supportive therapeutic space for siblings to explore their 
concerns or unanswered questions (e.g. about heredity factors or their current and potential prospective role 
as a carer).
Why it is important to do this review
ASDs are common, lifelong disorders characterised by overt and subtle qualitative impairments in 
communication, social interaction and relatedness, and preferences for engaging in restricted interests and 
repetitive behaviours (WHO 1992). Difficulties with tolerating uncertainty, ambiguity, and change within and 
beyond the immediate environment are additional hallmark characteristics (APA 2013). Core ASD symptoms 
can impact significantly on daily social and occupational functioning during childhood and adulthood. 
Individuals with ASD may find it difficult to initiate and sustain interactions with others despite the desire for 
relationships (and increased social opportunities). Also, symptoms of ASD typically impact others in the family (
Hoefman 2014). Parents (carers) and siblings often must accommodate restricted interests and adherence to 
seemingly non-functional routines. Inherent difficulties with communication and interaction can adversely affect 
relationships with, and between, family members. The need to provide intensive and ongoing support to 
individuals with ASD can incur stress, anxiety and depression in carers, as well as poor perceived parental 
efficacy and coping (Karst 2012).
There is no cure for ASD per se, and the heterogeneity of the disorder negates the use of monotherapy. 
Instead, the more parsimonious approach is to develop combinations of interventions that 1) reduce or 
ameliorate the effect and impact of core ASD symptoms, and 2) support individuals and others around them to 
enhance their repertoire of skills (Smith 2014; Woodman 2015). Further, interventions are needed across the 
lifespan to address the needs of children as well as adults with ASD. There is promising evidence for the use 
of psychological interventions for individuals with ASD, such as behavioural and cognitive-behavioural (Lang 
2010; Spain 2015a; Sukhodolsky 2013), social cognition (Fletcher-Watson 2014), and skills-based 
interventions (Reichow 2013; Spain 2015b), but a limitation to these approaches is that they do not explicitly 
address relationship and communication issues between family members, nor do they seek to enhance familial 
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coping strategies or resilience factors. Similarly, a recent review has highlighted the potential effectiveness of 
parent training for ASD (Oono 2013), but this approach encourages parents to take on a more facilitative role, 
rather than specifically targeting their (potential) concurrent needs and the bi-directional relationship between 
individuals. Conversely, family therapy is a more inclusive intervention and has been found to be effective for 
different clinical populations (Carr 2009). Whether the structure or content of family therapy for individuals with 
ASD requires adaptation (as is the case for other psychological therapies), for example to accommodate the 
impact of inherent impairments, is not wholly clear. Undertaking a systematic review of the empirical data is 
important in order to:
1. ascertain the potential effectiveness and acceptability of formal family therapy work for individuals with 
ASD;
2. establish whether there are integral features of these approaches that are associated with improved 
outcomes; and
3. consider how best interventions can be tailored to the specific lifelong needs of this clinical population 
and their family members.
Objectives
To evaluate the clinical effectiveness and acceptability of family therapy as a treatment to enhance 
communication or coping for individuals with ASD and their family members. If possible, we will also seek to 
establish the economic costs associated with family therapy for this clinical population.
Methods
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs (in which participants were allocated by alternate 
allocation, for example according to days of the week). We excluded cross-over trials and studies employing 
non-RCT designs (such as case studies or case series), due to the methodological limitations these can incur.
Types of participants
Families that have at least one person  child or adolescent (aged 17 years and under) or adult (aged 18 
years and over)  diagnosed with an ASD.
We defined ASD according to clinical criteria of either the International Classification of Diseases (WHO 
1992), or the Diagnostic and Statistical Manual of Mental Disorders (APA 2013), and ideally (but not 
necessarily) diagnosed using standardised methods of assessment (e.g. the Autism Diagnostic Interview - 
Revised (Lord 1994), or the Autism Diagnostic Observation Schedule (Lord 2000)).
We defined family members as individuals from multi-generations (parents, grandparents, siblings, children, or 
spouses), either biologically related to the individual with ASD, or related through marriage or cohabitation. We 
also included non-professional carers (e.g. individuals providing foster or respite care) and significant others 
such as friends.
We included studies that described interventions delivered to participants residing in the same dwelling, or 
interventions offered to family members living separately.
We included studies in which participants had a comorbidity or were receiving other treatments concurrently to 
the family therapy, although the intention was to clarify this level of detail from reports or by contacting trial 
authors.
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Types of interventions
Family therapy
We included family therapy interventions delivered by at least one suitably qualified clinician, derived from 
systemic theories, and specifically focusing on understanding, enhancing and improving aspects of 
relationships between individuals with ASD and at least one family member; or between two or more members 
of the family of an individual with ASD (e.g. parents, or parents and siblings). We included the following 
modalities of family therapy: systemic therapy; structural family therapy; strategic family therapy; Milan 
approaches; solution-focused therapy; narrative therapy; and behavioural family therapy. The intervention had 
to have been offered either face-to-face or via web-based real-time sessions. We excluded studies that 
described pure bibliotherapy, psychoeducation or parent training techniques. There was no stipulation 
regarding the number or duration of sessions delivered.
Control condition
We included four main types of comparator interventions.
1. No treatment.
2. Provision of standard clinical care (i.e. treatment as usual).
3. A wait-list control (e.g. a delayed-start intervention).
4. An active comparator (e.g. an alternative psychological intervention such as applied behavioural analysis 
or cognitive behavioural therapy).
Types of outcome measures
We identified primary and secondary outcomes for individuals with ASD and family members. We included 
outcome measures that generated either dichotomous or continuous data. To be eligible for inclusion, outcome 
measures needed to be standardised and validated. While measures may not necessarily have been 
specifically validated for use with the ASDs population, many intervention studies that include participants with 
ASD utilise measures (e.g. self-report questionnaires) that have been validated in non-ASD samples (Lang 
2010; Reichow 2013; Spain 2015a; Spain 2015b). The intention was to describe the psychometric properties 
of outcome measures, when possible, and highlight whether there are indicative, normative thresholds (that is, 
cut-off scores) for ASD samples.
Outcome measures could have been completed by individuals with ASD, family members, or via objective 
(clinician-administered) instruments. Outcome measures could have been completed at different time points, 
including postintervention or at follow-up, or relating to short-term changes (such as attributions about coping 
or satisfaction with the intervention), and longer-term outcomes (such as direct and indirect costs).
Primary outcomes
1. Quality or quantity of social interaction and communication (e.g. Social Responsiveness Scale by 
Constantino 2003; Autism Diagnostic Observation Schedule by Lord 2000).
2. Mental health morbidity, including stress, anxiety or depression (e.g. Hospital Anxiety and Depression 
Scale by Zigmond 1983).
3. Quality of life (e.g. EQ-5D by Szenda 2007), including quality of relationships with family members (e.g. 
Family Questionnaire by Wiedemann 2002).
4. Adverse effects or events (e.g. increased mental health morbidities, as measured by the Hospital Anxiety 
and Depression Scale (Zigmond 1983); or an increase in challenging behaviour).
Secondary outcomes
1. Confidence in, or attributions about, coping (e.g. Attributional Style Questionnaire by Seligman 1984).
2. Satisfaction with treatment (e.g. Client Satisfaction Questionnaire by Attkisson 1982).
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3. Dropout from treatment.
4. Health economic outcomes, including direct costs (e.g. treatment costs) and indirect costs (e.g. use of 
clinical services or work absence due to stress).
Search methods for identification of studies
We used a search strategy that combined two concepts: the condition (ASD) AND intervention (family 
therapy). We did not limit the search by language, date, or publication status.
Electronic searches
We searched the following electronic databases and trial registers between 22 October and 4 November 2015 
and again in January 2017:
1. Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 11) in the Cochrane Library, 
which includes the Cochrane Developmental, Psychosocial and Learning Problems Specialised Register 
(searched 18 January 2017);
2. MEDLINE Ovid (1946 to December Week 1 2016);
3. MEDLINE Epub & In Process Ovid (searched 17 January 2017);
4. Embase Ovid (1974 to 2017 Week 03);
5. CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature (1937 onwards; searched 17 
January 2017);
6. Cochrane Database of Systematic Reviews (CDSR; 2017, Issue 1) part of the Cochrane Library 
(searched 18 January 2017);
7. Database of Abstracts of Reviews of Effects (DARE; 2015, Issue 2) part of the Cochrane Library 
(searched 18 January 2017);
8. ERIC EBSCO (Education Resources Information Center;1966 onwards; searched 17 January 2017);
9. PsycINFO Ovid (1967 to January Week 2 2017);
10. Sociological Abstracts ProQuest (1952 onwards; searched 18 January 2017);
11. Dissertation Abstracts International ProQuest (1743 onwards; searched 16 January 2017);
12. AutismData (autism.org.uk/autismdata; searched 18 January 2017);
13. UK Clinical Research Network Study Portfolio (UKCRN; public.ukcrn.org.uk; searched 18 January 2017);
14. ClinicalTrials.gov (clinicaltrials.gov; searched 18 January 2017);
15. World Health Organisation International Clinical Trials Registry Platform (WHO ICTRP; 
apps.who.int/trialsearch/default.asp; searched 18 January 2017).
The exact strategy for each database is reported in Appendix 1. See Appendix 2 for a detailed summary of the 
searches to date.
Searching other resources
We also undertook additional searches as follows: 1) we handsearched the reference lists of 10 review papers (
Banda 2015; Cridland 2014; Dababnah 2016; Da Paz 2017; Gingerich 2013; Goepfert 2015; Karst 2012; 
Kaslow 2012; Ramisch 2013; Wainer 2016); and 2) we contacted a number of clinicians, including researchers 
who have undertaken studies in the field, to ask if they knew of any studies not already identified by the 
searches.
Data collection and analysis
Selection of studies
Selection of studies involved several steps. We initially imported all citations retrieved from the searches into 
EndNote (EndNote X7). After removing duplicates, DS and JS independently screened the list of titles and 
abstracts for relevance. Next, DS and JS inspected full reports of studies that appeared relevant or for which 
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more information was needed. They then independently assessed each text for eligibility based on the 
inclusion criteria outlined above (Criteria for considering studies for this review). To enhance reliability and 
rigour, EP independently reviewed a random 25% of the total sample of all titles and abstracts obtained, and a 
random 25% of all full-text reports retrieved. There were no disputes about the screening and inspection of 
reports. We recorded our decisions in a study flow diagram (Moher 2009).
Data extraction and management
No studies met the inclusion criteria for this review (Criteria for considering studies for this review).
Please see the protocol (Spain 2015c) and Table 1 for more information on methods archived for use in future 
updates of this review.
Results
Description of studies
Results of the search
Please see Figure 1 for a flow diagram of the selection process.
Our searches yielded 4805 database records (Electronic searches), and four additional records from other 
sources (Searching other resources). We removed 1536 duplicates and reviewed 3273 records for eligibility 
(Criteria for considering studies for this review). Two review authors (DS, JS) independently screened all titles 
and abstracts. A third author (EP) screened 800 titles and abstracts (25%) independently to enhance rigour. 
We excluded 3234 records, as none of these pertained to RCTs of family therapy for people with ASD.
We retrieved a total of 37 full-text reports for further evaluation. Thirty-four reports were written in English, one 
was written in Chinese (Chen 2006), one in Japanese (Abe 2014), and one in German (Goll-Kopka 2009). 
None of these described RCTs of family therapy and all were excluded (see Excluded studies). One excluded 
study, Wagner 2014, made reference to another, potentially relevant study. We contacted the author on two 
occasions but no further information was available at this time, therefore we classified this as awaiting 
classification (Spain 2017 [pers comm]).
Included studies
None of the reports retrieved met the inclusion criteria for this review (Criteria for considering studies for this 
review).
Excluded studies
We excluded 37 reports. We excluded 11 discussion papers or reviews (Affleck 1982; Alonim 2004; Brockman 
2016; Coleman 2015; Heller 2015; Helps 2016; Johnson 2012; Lordi 1964; Pickard 2017; Smock Jordan 
2016; Wagner 2014), one observational report (Altiere 2009), one qualitative study (Coogle 2016), and 24 
intervention studies that were not RCTs of family therapy (Abe 2014; Aerts 2011; Allen 1980; Alquraini 2015; 
Bennett 1983; Bennett 1986; Casenhiser 2011; Chen 2006; Chou 1992; Clancy 1972; Davis 1991; George 
1988; Drahota 2008; Estreicher 1982; Goll-Kopka 2009; Keen 2010; NCT01919970; Pillay 2010; Roux 2013; 
Shank 1991; Siller 2013; Solomon 2008; Wang 2008; Whittingham 2009).
See Characteristics of excluded studies tables.
Risk of bias in included studies
Given that no studies met the review inclusion criteria (Criteria for considering studies for this review), we were 
unable to assess risk of bias.
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Effects of interventions
It was not possible to establish intervention effectiveness, given the absence of data.
Discussion
Summary of main results
We sought to establish the clinical and cost effectiveness of family therapy for individuals with ASD. Despite an 
extensive search, no RCTs met the a priori review inclusion criteria (Criteria for considering studies for this 
review), implying a gap in the literature. One study is awaiting classification as no further information is 
available at this time.
Overall completeness and applicability of evidence
We were unable to assess completeness and applicability of evidence as no studies were included in this 
review.
Quality of the evidence
We were unable to assess the quality of the evidence as no studies were included in this review.
Potential biases in the review process
We consider that our search was rigorous and comprehensive. We conducted searches in 13 databases, 
including seeking unpublished studies such as those described in dissertations and the grey literature. We also 
handsearched the reference lists of a number of systematic and literature reviews. Finally, we contacted a 
couple of study authors to ascertain whether they were aware of trial data that may be eligible for inclusion in 
this review.
Agreements and disagreements with other studies or reviews
No other systematic reviews focusing on RCTs of family therapy or systemic therapy for ASD were retrieved 
by our search. We identified (but excluded) a few non-randomised intervention studies that incorporated 
elements of systemic therapy for family members of individuals with ASD (e.g. George 1988; Goll-Kopka 
2009; Wagner 2014). Evidence from these studies suggests that knowledge and understanding of the core 
disorder (i.e. ASD), and coping styles may be improved postintervention, albeit that use of less rigorous study 
designs means that results should be interpreted with a degree of caution.
Authors' conclusions
Implications for practice
In spite of uncertainty about effects, it may be that family therapy is deemed clinically appropriate, either in 
conjunction with other prescribed treatments or as a stand-alone intervention. Decisions to use family therapy 
should be made in consultation with suitably qualified multidisciplinary professionals. Also, the use of family or 
systemic therapies should be informed by best practice guidance for clinical work with this population (NICE 
2012).
Implications for research
There are several implications for research. Building on the literature to date, there is a need for further 
intervention studies that employ methodologically rigorous trial designs (i.e. RCTs). This may include studies 
that examine the clinical utility and effectiveness of psychoeducation for family members, couples therapy to 
strengthen relationships and coping when one parent has ASD, and family or systemic therapy for parents, 
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siblings, grandparents and children of people with ASD, and dyads (e.g. members of two generations and 
young people or adults with ASD and members of the immediate and extended family). Whether particular 
systemic approaches glean more favourable outcomes is yet to be established, but this warrants further 
investigation. Similarly, consideration of treatment mediators and moderators would prove beneficial. As a 
secondary objective, intervention studies should undertake process evaluations to establish satisfaction and 
acceptability of these interventions for family members.
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Differences between protocol and review
We did not produce a 'Summary of findings' table(s), as planned, as no studies were included in this review.
Published notes
Characteristics of studies
Characteristics of included studies
Footnotes
Characteristics of excluded studies
Abe 2014
Reason for exclusion This is a non-RCT study examining the effectiveness of a support group for 
family members of people with developmental disabilities. This support group is 
not family therapy.
Aerts 2011
Reason for exclusion This is a non-RCT study comprising a psychiatric family treatment for family 
members of individuals with autism. The intervention was competency based and 
is not family therapy.
Affleck 1982
Reason for exclusion This is a review paper synthesising information about parent training approaches 
for individuals with developmental disabilities.
Allen 1980
Reason for exclusion This is a two-arm study comprising a transdisciplinary, early intervention 
programme for young children with, or known to be at risk of, developmental 
disabilities compared to a treatment-as-usual group. Neither intervention is family 
therapy.
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Alonim 2004
Reason for exclusion This is a discussion paper about an early-intervention approach for young people 
with ASD.
Alquraini 2015
Reason for exclusion This is a non-RCT study comprising a relationship-focused intervention to 
alleviate stress in mothers of people with ASD. The intervention is not family 
therapy per se.
Altiere 2009
Reason for exclusion This is a cross-sectional study investigating family dynamics and coping in 
parents of individuals with ASD.
Bennett 1983
Reason for exclusion This is a two-arm study comprising a family-oriented treatment for parents of 
children with disabilities (primarily cerebral palsy) compared to a wait-list control. 
Neither arm is family therapy.
Bennett 1986
Reason for exclusion This is a two-arm study comprising a family-oriented treatment for parents of 
children with disabilities (primarily cerebral palsy) compared to a wait-list control. 
Neither arm is family therapy.
Brockman 2016
Reason for exclusion This is a discussion paper, which provides an overview of the use of family 
therapy techniques for people with ASD and family members. No RCT primary 
data is outlined.
Casenhiser 2011
Reason for exclusion This is a two-arm RCT comprising a social-communication-based intervention for 
young children with autism compared to a community treatment group (treatment 
as usual). Neither arm is family therapy.
Chen 2006
Reason for exclusion This is a two-arm study comprising individualised hospital care for individuals 
with autism compared to a family intervention. Participants were not randomised 
to either arm.
Chou 1992
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Reason for exclusion This is a two-arm study comprising a task-focused intervention, which 
incorporated systemic techniques, for individuals with developmental disabilities 
compared with a control group receiving treatment as usual. Participants were 
not randomised to either intervention.
Clancy 1972
Reason for exclusion This is a description of a clinical programme of systemic and family-focused 
techniques for individuals with autism. This is not a research trial and patients 
were not randomised to the programme.
Coleman 2015
Reason for exclusion This is a discussion paper about psychoeducation for family members of 
individuals with ASD.
Coogle 2016
Reason for exclusion This is a qualitative study focusing on the experiences of family members 
following engagement in an early intervention.
Davis 1991
Reason for exclusion This is a two-arm RCT comprising a home-based, family-focused counselling 
scheme for Bangladeshi families who had children with a range of developmental 
disabilities compared to treatment as usual. Neither arm is family therapy.
Drahota 2008
Reason for exclusion This is a two-arm RCT comprising a 'building confidence' CBT intervention for 
young people with ASD compared with a wait-list control. Neither arm is family 
therapy.
Estreicher 1982
Reason for exclusion This is a single-arm study comprising family therapy techniques for families with 
individuals with developmental disabilities. Participants were not randomised to 
the intervention.
George 1988
Reason for exclusion This is a single-arm study comprising a therapeutic group based on systemic 
principles for grandparents and extended family members of individuals with 
developmental delays. The intervention is not family therapy albeit that it 
incorporates systemic techniques.
Goll-Kopka 2009
Reason for exclusion This is a description of 'The Frankfurt Multi-family Therapy Model' for families 
who have children with developmental or global disabilities or disorders. This is a 
pilot study and patients were not randomised to the programme.
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Heller 2015
Reason for exclusion This is a discussion paper and literature review about interventions for adults as 
they age. No primary data are provided, nor is the review specifically about family 
therapy in ASD.
Helps 2016
Reason for exclusion This is a discussion paper and narrative review about family therapy 
interventions for family members of individuals with ASD.
Johnson 2012
Reason for exclusion This is a review of therapeutic work with couples who have a child with ASD.
Keen 2010
Reason for exclusion This is a two-arm quasi-RCT comprising a parent-focused intervention offered via 
home-based sessions and a workshop for parents of children with ASD 
compared to a self-directed video intervention. Neither arm is family therapy.
Lordi 1964
Reason for exclusion This is a discussion paper providing an overview of infantile autism, including 
family-focused working.
NCT01919970
Reason for exclusion This registration form pertains to a two-arm RCT comprising an exposure-based 
CBT treatment, incorporating parent input for young people with ASD, compared 
to treatment as usual. Neither arm is family therapy.
Pickard 2017
Reason for exclusion This is a review and discussion paper about family-focused ways of working with 
individuals with ASD.
Pillay 2010
Reason for exclusion This is a single-arm study comprising a parent-focused intervention for parents 
who have children with ASD. The intervention is not family therapy.
Roux 2013
Reason for exclusion This is a two-arm RCT comprising a group Stepping Stones Triple P intervention 
for parents of children with a range of intellectual disabilities compared to a 
wait-list control. Neither arm is family therapy.
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Shank 1991
Reason for exclusion This is a single-arm study comprising a problem-solving technique for parents of 
a child with a disability. The intervention is not family therapy albeit that it 
incorporates systemic techniques.
Siller 2013
Reason for exclusion This is a two-arm RCT comprising a focused playtime intervention for parents of 
children with ASD compared with psychoeducation. Neither arm is family therapy.
Smock Jordan 2016
Reason for exclusion This is a discussion paper about solution-focused therapy techniques for family 
members of individuals with ASD. Case vignettes (non-RCT data) are provided.
Solomon 2008
Reason for exclusion This is a two-arm RCT comprising a parent-child interaction therapy for parents 
of children with ASD compared with a wait-list control. Neither arm is family 
therapy.
Wagner 2014
Reason for exclusion This is a discussion paper, which also makes reference to a single-arm 
intervention about a multi-systemic therapy for families of individuals with ASD. 
Participants were not randomised to the intervention.
Wang 2008
Reason for exclusion This is a two-arm RCT comprising a parent training intervention for parents of 
children with autism compared with a wait-list control. Neither arm is family 
therapy.
Whittingham 2009
Reason for exclusion This is a two-arm RCT comprising the Stepping Stones Triple P positive 
parenting programme for parents of children with ASD compared with a wait-list 
control. Neither arm is family therapy.
Footnotes
ASD: autism spectrum disorder; CBT: cognitive behavioural therapy; RCT: randomised controlled trial.
Characteristics of studies awaiting classification
Spain 2017 [pers comm]
Methods From a study by Wagner 2014, we noted the following sentence: "Building on the 
results from our pilot work, we obtained grant funding to conduct a small 
randomized clinical trial for youths with ASD and severe behavioral problems 
(expected N = 30)" (p 326). We contacted the senior author in 2016 and 2017 in 
order to clarify the status of the trial.
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Participants Not known
Interventions Not known
Outcomes Not known
Notes We corresponded with the senior author in 2016 and 2017 but insufficient detail 
about the study was available.
Footnotes
ASD: autism spectrum disorder.
Characteristics of ongoing studies
Footnotes
Summary of findings tables
Additional tables
1 Unused methods sections
Unused methods Description of methods
Data extraction and 
management
The data extraction form will include subheadings relating to the 
following areas.
1. Study methods (including methods of randomisation, allocation 
concealment, and blinding of research personnel or participants).
2. Ethical approval (provision of informed consent or assent).
3. Referral route (method through which individuals are referred or 
present for family therapy).
4. Participant demographics and clinical diagnoses (including ASD 
and comorbid diagnoses).
5. Instruments used to diagnose ASD (including clinician-administered 
assessments with either participants or informants).
6. Active and comparator interventions (modality, content and 
duration of the active and comparator interventions).
7. Outcome measurements (for individuals with ASD and their family 
members; and health outcome data, if cited).
8. Results (including descriptive and inferential statistical data, as well 
as study results).
9. Adverse events (e.g. whether there has been an increase in mental 
health morbidities).
10. Treatment fidelity (e.g. whether a manualised treatment approach 
was used, if treatment sessions were independently reviewed for 
adherence to the theoretical model, and the frequency and nature 
of clinical supervision for trial therapists).
We will attempt to separate the outcomes and results between sites for 
any multi-centre studies. In the event that data described appear 
ambiguous for any of the reports, we will contact the authors for 
clarification. If we are unable to liaise with report authors, we will 
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document this within the review, and the review team will discuss the 
discrepancies.
For any non-English language studies, we will endeavour to arrange for 
report translation.
Assessment of risk of bias in 
included studies
DS and JS will independently assess the risk of bias of all included 
studies across seven domains: random sequence generation; allocation 
concealment; blinding of participants and trial staff; blinding of outcome 
assessments; incomplete outcome data; selective outcome reporting; 
and any other potential sources of bias. For each included study, we will 
assign each of these domains one of three ratings: high risk of bias, low 
risk of bias, or unclear risk of bias. We have detailed criteria for rating 
various domains of bias below, with examples drawn from Chapter 8.5 of 
the Cochrane Handbook for Systematic Reviews of Interventions 
(Higgins 2011a).
Random sequence generation
1. High risk of bias: a non-random method is used to generate the 
sequence such as allocation by alternate days or geographical 
location of entry to the trial.
2. Low risk of bias: random methods (e.g. random number table or 
computer random number generator) are used to generate the 
sequence to produce comparable groups.
3. Unclear risk of bias: no or insufficient information is provided on the 
methods used to generate the sequence to permit a judgement of 
high or low risk of bias.
Allocation concealment
1. High risk of bias: participants and researchers may have been able 
to foresee assignment to intervention groups due to insufficient 
measures used to conceal allocation (such as open random 
allocation schedule, unsealed or non-opaque envelopes).
2. Low risk of bias: adequate methods are used to conceal the 
allocation (e.g. opaque envelope procedure, central allocation or by 
independent personnel outside of the research team), so that 
participants and researchers are unable to foresee or influence the 
assignment of intervention groups.
3. Unclear risk of bias: no or insufficient detail is provided on methods 
used to conceal the allocation sequence to permit a judgement of 
high or low risk of bias.
Blinding of participants and research personnel
1. High risk of bias: neither participants nor research personnel are 
blinded to the treatment group allocation or study hypotheses, and 
outcomes are likely to be influenced by such lack of blinding; or 
blinding is attempted and subsequently broken; or some 
participants and personnel are blinded while others are not blinded, 
which may introduce bias.
2. Low risk of bias: effective measures (e.g. placebo or sham therapy 
sessions) are used to blind study participants and research 
personnel from knowing intervention group allocation and study 
hypotheses; or when blinding is not possible, study authors are 
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able to justify that the outcome is unlikely to be influenced by the 
lack of blinding.
3. Unclear risk of bias: either the study did not address this outcome 
or insufficient details are provided on methods of blinding to permit 
a judgement of low or high risk of bias.
Blinding of outcome assessment
1. High risk of bias: outcome assessors are not blinded to treatment 
allocation of the study participants and the study hypothesis, and 
the outcomes are likely to be influenced by the lack of blinding.
2. Low risk of bias: objective measures (such as biomedical measures 
of cortisol levels) that are unlikely to be influenced by the lack of 
blinding outcome assessors are used; participants are unaware of 
which intervention they have been allocated to; or participants' 
knowledge of which intervention they are receiving does not 
mediate their response to subjective outcome measures.
3. Unclear risk of bias: there is a lack of detail on methods of blinding 
to permit a judgement of high or low risk of bias.
Incomplete outcome data
1. High risk of bias: reasons for missing data are likely to be related to 
the true outcome; missing data are not balanced across groups; or 
inappropriate methods are used to impute missing data.
2. Low risk of bias: no incomplete outcome data for each main 
outcome; reasons for missing data are unlikely to be related to true 
outcome; missing data are balanced across groups; or appropriate 
methods have been used to impute the data.
3. Unclear risk of bias: either the study did not address this outcome, 
or there is insufficient detail as regards to the amount, nature, and 
handling of incomplete outcome data to permit a judgement of low 
or high risk of bias.
Selective reporting
1. High risk of bias: not all prespecified outcomes are reported; or 
outcomes are reported using methods not prespecified and for only 
a subgroup of the sample; or outcomes are reported that were not 
prespecified; or outcomes are reported incompletely and cannot be 
included in a meta-analysis.
2. Low risk of bias: all outcomes are reported as prespecified in 
published protocol, or the protocol is not available but there is 
convincing text that suggests that all prespecified outcomes have 
been reported.
3. Unclear risk of bias: there is insufficient information (e.g. no 
protocol available) to permit a judgement of high or low risk of bias.
Other sources of bias
1. High risk of bias: the study raises other important concerns, such 
as bias relating to the study design or claims of fraudulence, or 
other sources of bias that are not covered by the above domains.
2. Low risk of bias: there is no evidence to suggest there are any 
other important concerns about bias not addressed in the domains 
stated above.
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3. Unclear risk of bias: there may be an additional risk of bias, but 
there is insufficient information to fully assess this risk, or it is 
unclear that the risk would introduce bias in the study results.
We will obtain a third opinion from EP, MF or FH should there be 
disagreement about the 'Risk of bias' assessment or a lack of consensus 
about any of the individual domains per study or in terms of the overall 
appraisal of the trial. We will also attempt to contact report authors to 
provide clarification about aspects of the trial, as needed.
'Summary of findings' tables We will import data from Review Manager (Review Manager 2014), into 
GRADEprofiler (GRADEpro GDT), and use this software to create 
'Summary of findings' tables. These tables will provide outcome-specific 
information concerning the overall quality of the body of evidence from 
the studies included in the comparison, the magnitude of effect of the 
interventions examined, and the sum of available data on outcomes 
rated as relevant to patient care and decision making. 
 
We will employ the GRADE approach to assess the quality of evidence 
(Schünemann 2011), using the following ratings: high quality (RCTs or 
quasi-RCTs with a very low risk of bias), moderate quality (RCTs or 
quasi-RCTs with some evidence of risk of bias such as inadequate 
allocation concealment), low and very low quality (RCTs or quasi-RCTs 
that have significant threats to internal study validity such as failure to 
adequately randomise participants, lack of blinding of outcome 
assessors, or selective outcome reporting) (Schünemann 2011, Table 
12.2.a).
We will include the following outcomes in the 'Summary of findings' 
tables.
1. Quality or quantity of social interaction or communication.
2. Mental health morbidity, including stress, anxiety, or depression.
3. Quality of life.
4. Confidence in or attributions about coping.
5. Adverse effects or events.
Measures of treatment effect Dichotomous data
For dichotomous outcomes, such as the presence or absence of 
challenging behaviour(s), we will use the Mantel-Haenszel method for 
computing the pooled risk ratio (RR) (Mantel 1959). We will use the RR 
in meta-analyses, rather than the odds ratio (OR), because the OR can 
be susceptible to misinterpretation, which can lead to overestimation of 
the benefits and harms of the intervention (Deeks 2011, Section 9.4.4.4). 
We will report the RR with 95% CIs.
Continuous data
When different measures are used, we will calculate the standardised 
mean difference and 95% CI. We will calculate the mean difference and 
95% CI when all outcomes are measured using the same scale in the 
same way.
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Unit of analysis issues Cluster trials
In cluster trials, the independence of individuals cannot be assumed 
(Higgins 2011b). As we are examining the effectiveness of an 
intervention for both individuals and family members, we may identify 
cluster-randomised trials.
If clustering has been incorporated into the analyses of primary studies, 
we plan to present these data as if from a non-cluster-randomised study, 
but adjust for the clustering effect. We will contact study authors for more 
information if needed. If we identify cluster trials that have been analysed 
using incorrect statistical methods (i.e. not taking the clustering into 
account), we will contact study authors to request individual participant 
data so that we may calculate an estimate of the intracluster correlation 
coefficient (ICC). If we are unable to obtain this information, we will 
adjust sample sizes using an estimate of the ICC from the trial or from a 
trial of a similar population, with advice from a statistician, and use this to 
re-analyse the data. In the event that we are unable to adjust for 
incorrect statistical methods used by the cluster trials, and therefore 
cannot estimate the ICC with any a degree of confidence, we will 
exclude the trial (Higgins 2011b).
We will investigate the robustness of our results by conducting sensitivity 
analyses, for example, to explore the impact of different types of 
cluster-randomisation units (such as families, health practitioners) 
(Higgins 2011b). We will also compare the results with and without 
cluster trials that have not been analysed correctly by the trialists (where 
the ICC is estimated from other trials for the adjustment of cluster effect) 
(see Sensitivity analysis).
Cross-over trials
Due to the issue of carry-over, that is, whereby the effectiveness of a 
second intervention may be mediated by the first intervention, we will 
exclude cross-over trials.
Multiple comparisons
Where a trial involves more than two treatment (or comparator) arms, we 
will first assess which intervention (or comparator) groups are relevant to 
our review. We will use data from the arms of the trial that are relevant to 
the review objectives, but present all intervention groups in the 
'Characteristics of included studies' tables, providing a detailed 
description of why we have selected particular groups and excluded 
others. In the event that studies have more than two intervention groups 
and a control group that are relevant to the review, we will split the 
control group data proportionately to the other two groups.
Repeated measures
When a trial reports outcome data obtained at more than one time point, 
we will conduct analyses separately for each time point (e.g. 
postintervention and at follow-up, if follow-up is specified by the trialist).
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Dealing with missing data We will consider the possible impact of missing data on the results of the 
review.
Data may be missing either because (1) they have been insufficiently or 
inadequately reported, or (2) due to dropout or attrition. In the event of 
insufficient or inadequate reporting, we will first try to obtain any missing 
data from the trial authors, including unreported data (e.g. group means 
and SDs), details of dropouts, and interventions provided. We will 
describe the missing data in the 'Risk of bias' table.
In either case outlined above, and when we cannot obtain data, we will 
conduct analyses using ITT principles. For dichotomous outcomes 
(those not deemed to be missing at random), we will impute the 
outcomes for the missing participants using both the most optimistic (i.e. 
assuming participants with missing data improve) and the most 
pessimistic (i.e. assuming participants with missing data deteriorate) 
scenarios.
When data are missing for continuous outcomes (e.g. data pertaining to 
means or SD), we will attempt to calculate them based on the standard 
errors, CIs, and t values, according to the rules described in the 
Cochrane Handbook for Systematic Reviews of Interventions (Higgins 
2011c). If this information is missing, and we are unable to obtain it from 
trial authors, we will report it as missing data in the review.
We will also conduct a sensitivity analysis to compare the results from 
the ITT analysis with the imputation and available case  analysis (see 
Sensitivity analysis). If these analyses yield similar results in terms of the 
effects of treatment, we will present the results of the available case 
analyses.
Assessment of heterogeneity Within each comparison, we will first assess clinical heterogeneity (e.g. 
variability in active and comparator interventions, participant 
characteristics, or outcome measures used) and methodological 
heterogeneity (e.g. variability in study design, including differences in the 
nature of the randomisation unit and the size of cluster randomised; and 
risk of bias, which we will assess according to the criteria outlined in the 
Cochrane Handbook for Systematic Reviews of Interventions (Deeks 
2011)). If there is clinical or methodological heterogeneity, we will extract 
and document all of these characteristics onto the data extraction form 
and synthesise the results narratively. We will then assess statistical 
heterogeneity using the I² and Chi² statistics, and by visually inspecting 
the forest plots. If we identify a substantial level of heterogeneity in trials 
(e.g. the I² is more than 30% to 60%, the P value is less than 0.10 in the 
Chi² test for heterogeneity, or there is a different direction of the effects), 
we will conduct prespecified subgroup analyses (see Subgroup analysis 
and investigation of heterogeneity).
Assessment of reporting biases We will assess reporting biases, including (multiple) publication, 
selective reporting, outcome and language biases (Sterne 2011, Table 
10.1.a). First, we will try to locate protocols of included trials. If the 
protocol is available, we will compare outcomes documented in the 
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protocol and the published report. If the protocol is not available, we will 
compare outcomes listed in the methods section of the trial report with 
the reported results. In addition, we will create funnel plots to investigate 
the possibility of publication bias and other small-study effects when 
there is a sufficient number of trials (10 or more). While funnel plots may 
be useful in investigating reporting biases, there is some concern that 
tests for funnel plot asymmetry have limited power to detect small-study 
effects, particularly when there are fewer than 10 studies, or when all 
studies are of a similar sample size (Sterne 2011). In the event that 
funnel plots are possible, we will produce them and seek statistical 
advice in their interpretation.
Data synthesis We will conduct random-effects meta-analyses to produce the average 
effect size of the intervention across trials. A random-effects model is 
considered more appropriate than a fixed-effect model because the 
population and setting of trials are likely to be different, and therefore the 
effects are also likely to be different (Deeks 2011).
Subgroup analysis and 
assessment of heterogeneity
Depending on the sample size and heterogeneity of study populations, 
we propose to undertake subgroup analyses as follows:
1. children and adolescents (aged 17 years and under) versus adults 
(aged 18 years and above) with ASD; and
2. individuals with ASD who have a concurrent learning disability (i.e. 
IQ below 70) versus individuals with ASD and no learning disability.
To limit the risk of multiple comparisons, we will conduct subgroup 
analyses on primary outcomes only.
Sensitivity analysis We will undertake sensitivity analyses to evaluate the impact of 
excluding trials (or trial data) that are judged to have a high risk of bias 
(e.g. in terms of the domains of random sequence generation, allocation 
concealment, blinding, or outcome reporting). We will also undertake 
sensitivity analyses to assess the potential impact of missing outcome 
data.
Footnotes
ASD: autism spectrum disorder; CI: confidence interval; GRADE: Grades of Recommendation, Assessment, 
Development and Evaluation; ITT: intention-to-treat; IQ: intelligence quotient; RCTs: randomised controlled 
trials; SD: standard deviation.
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1 Search strategy
Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane 
Library
#1[mh "child development disorders, pervasive"] 
#2[mh ^"Developmental Disabilities"] 
#3pervasive development* disorder* 
#4(pervasive near/3 child*) 
#5(PDD or PDDs or PDD-NOS or ASD or ASDs) 
#6autis* 
#7asperger* 
#8kanner* 
#9childhood near/1 schizophreni* 
#10{or #1-#9} 
#11[mh "family therapy"] 
#12[mh "group therapy"] 
#13[mh "psychotherapy, group"] 
#14[mh "couples therapy"] 
#15[mh "marital therapy"] 
#16(systemic* near/3 psychotherap*) 
#17(systemic* near/3 psycho-therap*) 
#18(systemic* near/3 famil*) 
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#19(famil* near/3 (intervention* or therap* or treat* or program*)) 4 
#20(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*)) 3 
#21((marriage or marital or couple*) near/3 therap*) 
#22(famil* near/1 (involv* or integrat* or participat* or focus*)) 
#23(psychodynamic or psycho next dynamic) 
#24(group* near/3 psychotherap*) 
#25(group* near/3 psycho next therap*) 
#26(systemic next therap*) 
#27(solution next focus*) 
#28(narrative near/3 therap*) 
#29{or #11-#28} 
#30#10 and #29 in Trials 
MEDLINE Ovid; MEDLINE Ovid Epub; MEDLINE Ovid In-Process
1 exp child development disorders, pervasive/ 
2 Developmental Disabilities/ 
3 pervasive development$ disorder$.tw. 
4 (pervasive adj3 child$).tw. 
5 (PDD or PDDs or PDD-NOS or ASD or ASDs).tw. 
6 autis$.tw. 
7 asperger$.tw. 
8 kanner$.tw. 
9 childhood schizophreni$.tw. 
10 or/1-9 
11 family therapy/ 
12 group therapy/ 
13 psychotherapy, group/ 
14 couples therapy/ 
15 marital therapy/ 
16 (systemic$ adj3 psychotherap$).tw. 
17 (systemic$ adj3 psycho-therap$).tw. 
18 (systemic$ adj3 famil$).tw. 
19 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw. 
20 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw. 
21 ((marriage or marital or couple$) adj3 therap$).tw. 
22 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw. 
23 (psychodynamic or psycho-dynamic).tw. 
24 (group$ adj3 psychotherap$).tw. 
25 (group$ adj3 psycho-therap$).tw. 
26 systemic therap$.tw. 
27 solution focus$.tw. 
28 (narrative adj1 therap$).tw. 
29 or/11-28 
30 10 and 29
Embase OVID
1 exp autism/ 
2 pervasive development$ disorder$.tw. 
3 (PDD or PDDs or ASD or ASDs).tw. 
4 autis$.tw. 
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5 asperger$.tw. 
6 kanner$.tw. 
7 childhood schizophreni$.tw. 
8 Rett$.tw. 
9 (pervasive adj3 child$).tw. 
10 or/1-9 
11 family therapy/ 
12 group therapy/ 
13 marital therapy/ 
14 (systemic$ adj3 psychotherap$).tw. 
15 (systemic$ adj3 psycho-therap$).tw. 
16 (systemic$ adj3 famil$).tw. 
17 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw. 
18 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw. 
19 ((marriage or marital or couple$) adj3 therap$).tw. 
20 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw. 
21 (psychodynamic or psycho-dynamic).tw. 
22 (group$ adj3 psychotherap$).tw. 
23 (group$ adj3 psycho-therap$).tw. 
24 systemic therap$.tw. 
25 solution focus$.tw. 
26 (narrative adj1 therap$).tw. 
27 or/11-26 
28 10 and 27
CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature)
S27 S9 AND S26 
S26 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR 
S22 OR S23 OR S24 OR S25 
S25 (narrative N1 therap*) 
S24 solution focus* 
S23 systemic therap* 
S22 (group* N3 (psychotherap* or psycho-therap*) ) 
S21 (psychodynamic or psycho-dynamic) 
S20 (famil* N1 (involv* or integrat* or participat* or focus*)) 
S19 ((marriage or marital or couple*) N3 therap*) 
S18 (famil* N3 (psychotherap* or psychoeducation* or psycho-education*or psycho-therap*)) 
S17 (famil* N3 (intervention* or therap* or treat* or program*)) 
S16 (systemic* N3 famil*) 
S15 (systemic* N3 psycho-therap*) 
S14 (systemic* N3 psychotherap*) 
S13 (MH "Couples Counseling") 
S12 (MH "Psychotherapy, Group") 
S11 (MH "Family Therapy") 
S10 (MH "Family Systems Theory") OR (MH "Family Services") 
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 
S8 (MH "Developmental Disabilities") 
S7 childhood schizophren* 
S6 Kanner* 
S5 Rett* 
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S4 Asperger* 
S3 (autis* or ASD or ASDs) 
S2 (pervasive development* disorder* or PDD or PDDs) 
S1 (MH "Child Development Disorders, Pervasive+")
Cochrane Database of Systematic Reviews (CDSR) part of the Cochrane Library
#1[mh "child development disorders, pervasive"] 
#2[mh ^"Developmental Disabilities"] 
#3"pervasive development* disorder*":ti,ab 
#4(pervasive near/3 child*):ti,ab 
#5autis* :ti,ab 
#6asperger*:ti,ab 
#7kanner*:ti,ab 
#8{or #1-#7} 
#9[mh "family therapy"] 
#10[mh "group therapy"] 
#11[mh "psychotherapy, group"] 
#12[mh "couples therapy"] 
#13[mh "marital therapy"] 
#14(systemic* near/3 psychotherap*):ti,ab 
#15(systemic* near/3 psycho-therap*):ti,ab 
#16(systemic* near/3 famil*):ti,ab 
#17(famil* near/3 (intervention* or therap* or treat* or program*)):ti,ab 
#18(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*)):ti,ab 
#19((marriage or marital or couple*) near/3 therap*):ti,ab 
#20(famil* near/1 (involv* or integrat* or participat* or focus*)):ti,ab 
#21(psychodynamic or psycho next dynamic):ti,ab 
#22(group* near/3 psychotherap*):ti,ab 
#23(group* near/3 psycho next therap*):ti,ab 
#24("systemic therap*"):ti,ab 
#25("solution focus*"):ti,ab 
#26(narrative near/1 therap*):ti,ab 
#27{or #9-#26} 
#28#8 and #27
Database of Abstracts of Reviews of Effects (DARE) part of the Cochrane Library
#1[mh "child development disorders, pervasive"] 
#2[mh ^"Developmental Disabilities"] 
#3"pervasive development* disorder*" 
#4(pervasive near/3 child*) 
#5autism or autistic 
#6asperger* 
#7kanner*: 
#8{or #1-#7} 
#9[mh "family therapy"] 
#10[mh "group therapy"] 
#11[mh "psychotherapy, group"] 
#12[mh "couples therapy"] 
#13[mh "marital therapy"] 
#14(systemic* near/3 psychotherap*) 
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#15(systemic* near/3 psycho-therap*) 
#16(systemic* near/3 famil*): 
#17(famil* near/3 (intervention* or therap* or treat* or program*)) 
#18(famil* near/3 (psychotherap* or psychoeducation* or psycho next education* or psycho next therap*)) 
#19((marriage or marital or couple*) near/3 therap*) 
#20(famil* near/1 (involv* or integrat* or participat* or focus*)) 
#21(psychodynamic or psycho next dynamic) 
#22(group* near/3 psychotherap*) 
#23(group* near/3 psycho next therap*) 
#24("systemic therap*") 
#25("solution focus*"): 
#26(narrative near/1 therap*) 
#27{or #9-#26} 
#28#8 and #27
ERIC Ebsco (Education Resources Information Center)
S27 S9 AND S26 
S26 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR 
S22 OR S23 OR S24 OR S25 
S25 (narrative N1 therap*) 
S24 "solution focus*" 
S23 "systemic therap*" 
S22 (group* N3 (psychotherap* or psycho-therap*)) 
S21 (psychodynamic or psycho-dynamic) 
S20 TI(famil* N1 (involv* or integrat* or participat* or focus*)) OR AB(famil* N1 (involv* or integrat* or 
participat* or focus*) 
S19 TI ((marriage or marital or couple*) N3 therap*) OR AB((marriage or marital or couple*) N3 therap*) 
Search modes - Boolean/Phrase 
S18 TI(famil* N3 (psychotherap* or psychoeducation* or psycho-education* or psycho-therap*))OR AB(famil* 
N3 (psychotherap* or psychoeducation* or psycho-education* or psycho-therap*)) 
S17 TI(famil* N3 (intervention* or therap* or treat* or program*)) OR AB(famil* N3 (intervention* or therap* or 
treat* or program*)) 
S16 (systemic* N3 famil*) 
S15 (systemic* N3 psycho-therap*) 
S14 (systemic* N3 psycho-therap*) 
S13 (systemic* N3 psychotherap*) 
S12 DE "Marriage Counseling" 
S11 DE "Group Counseling" OR DE "Group Therapy" 
S10 DE "Family Counseling" OR DE "Family Involvement" OR DE "Family Programs" 
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 
S8 childhood schizophren* 
S7 Kanner* 
S6 Rett* 
S5 Asperger* 
S4 (autis* or ASD or ASDs) 
S3 (pervasive development* disorder* or PDD or PDDs) 
S2 DE "Pervasive Developmental Disorders" OR DE "Asperger Syndrome" OR DE "Autism" 
S1 DE "Developmental Disabilities"
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PsycINFO (Ovid)
1 exp pervasive developmental disorders/ 
2 Developmental disabilities/ 
3 pervasive development$ disorder$.tw. 
4 (pervasive adj3 child$).tw. 
5 autis$.tw. 
6 asperger$.tw. 
7 (autis$ or ASD or ASDs).tw. 
8 Rett$.tw. 
9 Kanner$.tw. 
10 (PDD or PDDs or PDD-NOS).tw. 
11 childhood schizophreni$.tw. 
12 or/1-11 
13 exp family therapy/ 
14 family intervention/ 
15 group psychotherapy/ 
16 conjoint therapy/ 
17 couples therapy/ 
18 marriage counseling/ 
19 (systemic$ adj3 psychotherap$).tw. 
20 (systemic$ adj3 psycho-therap$).tw. 
21 (systemic$ adj3 famil$).tw. 
22 (famil$ adj3 (intervention$ or therap$ or treat$ or program$)).tw. 
23 (famil$ adj3 (psychotherap$ or psychoeducation$ or psycho-education$ or psycho-therap$)).tw. 
24 ((marriage or marital or couple$) adj3 therap$).tw. 
25 (famil$ adj1 (involv$ or integrat$ or participat$ or focus$)).tw. 
26 (psychodynamic or psycho-dynamic).tw. 
27 (group$ adj3 psychotherap$).tw. 
28 (group$ adj3 psycho-therap$).tw. 
29 systemic therap$.tw. 
30 solution focus$.tw. 
31 (narrative adj1 therap$).tw. 
32 or/13-31 ( 
33 12 and 32
Sociological Abstracts Proquest
SU.EXACT("Autism") OR autis* or asperger* or kanner* or Rett* or pervasive N3 disorder* or pervasive N3 
child* OR PDD or PDDs or PDD-NOS or ASD or ASDs) AND ((famil* N/3 (intervention* or therap* or treat* or 
program*)) or (famil* N/3 (psychotherap* or psychoeducation* or "psycho education*" or "psycho therap*")) or 
(systemic* N/3 psychotherap*) or (systemic* N/3 "psycho- therap*") or (famil* N/1 (involv* or integrat* or 
participat* or focus*)) OR (group* N/3 psychotherap*) or systemic therap* or (group* N/3 psychotherap*) or 
(group* N/3 ("psycho-therap*" or psychoeducation* or "psycho education*" or "psycho therap*")))
Dissertation Abstracts International Proquest
(ab(child developmental disorders) OR ab((pervasive developmental disorders OR developmental disabilit$)) 
OR ab((pervasive development$ disorder$ OR pervasive adj3 child$)) OR ab((PDD OR PDDs OR PDD-NOS 
OR ASD OR ASDs OR autis$)) OR ab((asperger$ OR kanner$)) OR ab(childhood schizophrenia)) AND 
(ab(family therapy) OR ab((group therapy OR group psychotherapy)) OR ab((couples therapy OR marital 
therapy)) OR ab((systemic$ adj3 psychotherap$ OR systemic$ adj3 psycho-therap$)) OR ab((systemic$ adj3 
famil$ OR famil$ adj3 (intervention$ OR therap$ OR treat$ OR program$))) OR ab((famil$ adj3 
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(psychotherap$ OR psychoeducation$ OR psycho-education$ OR psycho-therap$) OR (marriage OR marital 
OR couple$) adj3 therap$)) OR ab((famil$ adj1 (involv$ OR integrat$ OR participat$ OR focus$) OR 
psychodynamic OR psycho-dynamic)) OR ab((group$ adj3 psychotherap$ OR group$ adj3 psycho therap$)) 
OR ab((systemic therap$ OR solution focus$)) OR ab(narrative adj1 therap))
AutismData
(autism.org.uk/autismdata)
Searched "family therapy" as keyword
Records were compared manually with EN library; 6 unique records added to Endnote
UK Clinical Research Network (UKCRN) Study Portfolio
(public.ukcrn.org.uk/search)
Searches:
Speciality : Mental health 
Subtopic: Autism spectrum disoders 
Research summary: family
Speciality : Mental health 
Subtopic: Autism spectrum disoders 
Research summary: systemic
Speciality : Mental health 
Subtopic: Autism spectrum disoders 
Research summary: psychotherapy
Speciality : Mental health 
Subtopic: Autism spectrum disoders 
Research summary: multisystemic
ClinicalTrials.gov
(clinicaltrials.gov/ct2/home)
autism | (family OR systemic OR group) AND (therapy) OR autism | (family OR systemic OR group) AND 
(psychotherapy)
World Health Organisation International Clinical Trials Registry Platform (WHO 
ICTRP)
(apps.who.int/trialsearch/AdvSearch.aspx)
Basic search: Autism AND group OR autism AND family or autism AND parent OR autism AND systemic 
2 Record of searches
Database
Search 
date
Date 
range/issue
Numb
er of 
recor
ds
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Cochrane Central Register of Controlled Trials (CENTRAL) in the 
Cochrane Library
23 
October 
2015
Issue 9 of 12, 
September 2015
75
18 
January 
2017
Issue 11 of 12, 
November 2016
15
MEDLINE Ovid 22 
October 
2015
1946 to October 
Week 3 2015
559
17 
January 
2017
1946 to December 
Week 1 2016
74
MEDLINE Ovid Epub 17 
January 
2017
16 January 2017 15
MEDLINE Ovid In Process 17 
January 
2017
16 January 2017 39
Embase OVID 22 
October 
2015
1974 to 2015 Week 
42
695
17 
January 
2017
1974 to 2017 Week 
3
94
CINAHL EBSCO (Cumulative Index to Nursing and Allied Health 
Literature)
23 
October 
2015
1937 to current 402
17 
January 
2017
1937 to current 22
Cochrane Database of Systematic Reviews (CDSR) part of the 
Cochrane Library
23 
October 
2015
Issue 10 of 12, 
October 2015
15
18 
January 
2017
Issue 1 of 12, 
January 2015
6
Database of Abstracts of Reviews of Effects (DARE) in the 
Cochrane Library
23 
October 
2015
Issue 2 of 4, April 
2015
4
ERIC EBSCO (Education Resources Information Center) 23 
October 
2015
1966 to current 564
Family therapy for autism spectrum disorders 03-May-2017
Review Manager 5.3 44
17 
January 
2017
1966 to current 32
PsycINFO OVID 22 
October 
2015
1967 to October 
Week 3 2015
1417
17 
January 
2017
1967 to January 
Week 2 2017
118
Sociological Abstracts ProQuest 23 
October 
2015
1952 to current 52
18 
January 
2017
1952 to current 4
Dissertation Abstracts International ProQuest 4 
November 
2015
1743 to current 176
16 
January 
2017
1743 to current 215
AutismData (autism.org.uk/autismdata) 23 
October 
2015
All years 6
18 
January 
2017
All years 4
UK Clinical Research Network Study Portfolio (UKCRN; 
public.ukcrn.org.uk/search)
23 
October 
2015
All years 1
UK Clinical Trials Gateway (UKCTG; ukctg.nihr.ac.uk) 18 
January 
2017
All years 1
ClinicalTrials.gov ( clinicaltrials.gov/ct2/home) 23 
October 
2015
All years 82
18 
January 
2017
All years 24
World Health Organisation International Clinical Trials Registry 
Platform (WHO ICTRP; apps.who.int/trialsearch/AdvSearch.aspx)
23 
October 
2015
All years 91
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18 
January 
2017
All years 3
Total records 4805
